AP NEWS

Europe Raynaud’s Disease Market and Competitive Landscape - 2018 - ResearchAndMarkets.com

December 5, 2018

DUBLIN--(BUSINESS WIRE)--Dec 5, 2018--The “Europe Raynaud’s Disease Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

The latest research Europe Raynaud’s Disease Market and Competitive Landscape - 2018, provides comprehensive insights into Raynaud’s Disease pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Raynaud’s Disease market size and drug sales. This research also provides insights into Raynaud’s Disease epidemiology and late stage pipeline.

Research Scope

Raynaud’s Disease pipeline: Find out the drugs in clinical trials for Raynaud’s Disease by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by companyRaynaud’s Disease epidemiology: Find out the prevalence of Raynaud’s Disease by countries - Europe, Germany, France, Italy, Spain, UK; prevalence forecast to 2023Raynaud’s Disease products: Identify key products marketed and prescribed for Raynaud’s Disease by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UKRaynaud’s Disease market size: Find out the market size for Raynaud’s Disease drugs by countries - Europe, Germany, France, Italy, Spain, UK; Find out how the market advanced from 2014Raynaud’s Disease drug sales: Find out the sales of Raynaud’s Disease drugs by countries - Europe, Germany, France, Italy, Spain, UKRaynaud’s Disease drugs sales forecast: Sales forecast for Raynaud’s Disease drugs to 2023 by countries - Europe, Germany, France, Italy, Spain, UKRaynaud’s Disease market share analysis: Find out the market shares of Raynaud’s Disease drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK

For more information about this report visit https://www.researchandmarkets.com/research/2tvvvx/europe_raynauds?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181205005343/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH CARDIOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/05/2018 06:52 AM/DISC: 12/05/2018 06:52 AM

http://www.businesswire.com/news/home/20181205005343/en

AP RADIO
Update hourly